Psychotropics for toddlers?

by Olivia Murray at

A patient healed is a customer lost.

Little Rebecca Riley was just two years old when a Boston psychiatrist diagnosed her with bipolar disorder and ADHD, prescribing her with a host of psychotropic drugs; by age four, she was dead from overmedication. Now, while Rebecca’s parents went to prison, Dr. Kayoko Kifuji never faced any serious consequences for her role in Rebecca’s death (and subsequent negligence or oversight), and as far as I can tell, is still “practicing” medicine.

This morning, a reader sent us a report from Frontline News which detailed Rebecca’s story and the subsequent 2010 criminal trials—but the piece also highlighted an aspect of the pharmaceutical-industrial-complex (PIC) that all too often escapes our attention: children dosed with psychotropic drugs.

From that Frontline item:

According to the CDC, in 2022, 9.3 percent of children aged between 5 and 17 were taking drugs for their ‘mental health.’ This translates to around five million children. As many anti-Pharma activists have pointed out, children are a very sought-after demographic for drugging, as they usually have little to no say as to whether to take the drugs or not, even when adverse events are disturbing, painful, and/or outright harmful. Furthermore, a childhood on drugs very often predicts adult life on more drugs—more of the same, plus others.

That’s a 2022 stat—I wonder where some of those kids are now? Oh I don’t know, probably LARPing around Ivy League campuses and vandalizing property as they don terrorist scarves and wave signs calling for the invocation of the Third Reich’s “final solution” strategy: